JOSEPH ST. LAURENT,GERALD S. JONES,DAVID M. BRESSE
申请号：
US15339196
公开号：
US20170105962A1
申请日:
2016.10.31
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ω-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(arylsulfonyl)alkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
